Broker Recommendations Amgen Inc.

Stocks

AMGN

US0311621009

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 17/07/2026 BST			5-day change	1st Jan Change
366.29 ^USD	-1.42%		+0.80%	+11.91%

07-16	Merck gets US FDA nod for first-in-its-class oral cholesterol drug	RE
07-13	BofA Securities Adjusts Amgen Price Target to $312 From $307	MT

Broker Recommendations

07-13	BofA Securities Adjusts Amgen Price Target to $312 From $307	MT
07-13	UBS Adjusts Price Target on Amgen to $420 From $400, Maintains Buy Rating	MT
07-08	Morgan Stanley Adjusts Price Target Amgen to $333 From $340, Maintains Equalweight Rating	MT
07-07	Truist Securities Adjusts Amgen Price Target to $340 From $327	MT
07-06	Rothschild & Co Redburn Adjusts Price Target on Amgen to $220 From $200	MT
06-18	Amgen's Diversified Business, Emerging Pipeline Drives Positive View, RBC Says	MT
06-15	Mizuho Securities Lifts Price Target on Amgen to $303 From $295, Keeps Outperform Rating	MT
06-10	Morgan Stanley Adjusts Amgen Price Target to $340 From $332, Maintains Equal Weight Rating	MT
05-20	Argus Adjusts Price Target on Amgen to $375 From $400, Maintains Buy Rating	MT
05-14	Piper Sandler Adjusts Price Target on Amgen to $427 From $432, Maintains Overweight Rating	MT
05-13	Daiwa Securities Adjusts Price Target on Amgen to $390 From $410, Maintains Outperform Rating	MT
05-06	DZ Bank Lowers Its Price Target on Amgen
05-04	Guggenheim Adjusts Price Target on Amgen to $340 From $351, Maintains Neutral Rating	MT
05-01	Amgen's Q1 EPS Beat Driven Lower Taxes, SG&A, Morgan Stanley Says	MT
05-01	Morgan Stanley Lifts Price Target on Amgen to $332 From $326, Keeps Equalweight Rating	MT
05-01	Goldman Sachs Adjusts Amgen Price Target to $425 From $415, Maintains Buy Rating	MT
04-28	Morgan Stanley Adjusts Price Target on Amgen to $326 From $309, Maintains Equalweight Rating	MT
04-21	Canaccord Genuity Initiates Amgen at Hold With $366 Price Target	MT
04-13	UBS Adjusts Price Target on Amgen to $400 From $390, Maintains Buy Rating	MT
04-09	Guggenheim Adjusts Amgen Price Target to $351 From $347, Maintains Neutral Rating	MT
04-07	RBC Capital Adjusts Amgen Price Target to $370 From $360, Maintains Outperform Rating	MT
04-02	Amgen's Diversification Continues To Pay Off, RBC Says	MT
03-19	Wells Fargo Adjusts Price Target on Amgen to $390 From $375, Maintains Equalweight Rating	MT
02-18	Wells Fargo Adjusts Amgen Price Target to $375 From $325, Maintains Equal Weight Rating	MT
02-18	Piper Sandler Adjusts Price Target on Amgen to $432 From $381, Maintains Overweight Rating	MT